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Introduction: Two hantavirus species, Puumala 
(PUUV) and Dobrava-Belgrade (DOBV) virus (geno-
type Kurkino), are endemic in Germany. Recent PUUV 
outbreaks raised questions concerning increasing fre-
quency of outbreaks and expansion of PUUV endemic 
areas. Aims: To describe the epidemiology of human 
PUUV and DOBV infections in Germany. Methods: We 
conducted an observational retrospective study ana-
lysing national hantavirus surveillance data notified 
to the national public health institute and hantavirus 
nucleotide sequences from patients collected at the 
national consultation laboratory between 2001 and 
2017. Matching molecular sequences with surveillance 
data, we conducted epidemiological, phylogenetic and 
phylogeographic analyses. Results: In total, 12,148 
cases of symptomatic hantavirus infection were noti-
fied 2001–17 (mean annual incidence: 0.87/100,000; 
range: 0.09–3.51). PUUV infections showed a highly 
variable space-time disease incidence pattern, caus-
ing large outbreaks every 2–3 years with peaks in 
early summer and up to 3,000 annually reported cases. 
Sex-specific differences in disease presentation were 
observed. Of 202 PUUV nucleotide sequences obtained 
from cases, 189 (93.6%) fall into well-supported phy-
logenetic clusters corresponding to different endemic 
areas in Germany. DOBV infections caused few, mostly 
sporadic cases in autumn and winter in the north 
and east of Germany. Conclusions: The frequency of 
PUUV outbreaks increased between 2001 and 2017 
but our data does not support the suggested expan-
sion of endemic areas. The epidemiology of PUUV and 
DOBV-Kurkino infections differs in several aspects. 
Moreover, the latter are relatively rare and combining 
efforts and data of several countries to identify risk 
factors and develop specific recommendations for pre-
vention could be worthwhile.
Introduction
Hantaviruses are a diverse group of small mammal-
associated viruses with a worldwide distribution. 
Depending on whether human infections are caused by 
New- or Old- World hantaviruses, the disease is charac-
terised by different clinical pictures and described as 
Hantavirus (Cardio-)Pulmonary Syndrome (HPS/HCPS) 
in the Americas and Haemorrhagic Fever with Renal 
Syndrome (HFRS) on other continents. Sometimes the 
term Nephropathia epidemica (NE) is used to describe 
the epidemic occurrence of renal disease without 
haemorrhagic symptoms that are linked to infections 
with strains occurring in the northern and central part 
of Europe, specifically Puumala virus (PUUV). In clini-
cal practice, syndromes are not always as clear cut as 
their names suggest and pulmonary and renal compli-
cations can also occur in HFRS and HPS/HCPS, respec-
tively [1-3].
Hantavirus infections are typically zoonotic. The 
viruses are carried by small mammals and are trans-
mitted to humans through inhalation of dust contami-
nated with saliva, faeces or urine of infected animals 
or through bites and probably also by ingestion of 
contaminated food [4]. All known human pathogenic 
hantaviruses are hosted by specific rodent species, 
however, novel hantaviruses have also been detected 
in shrews, moles and bats [5]. Some hantavirus spe-
cies can cause infection where the case fatality ratio 
can be up to 50% [1,6-8].
Most cases of hantavirus disease are reported from 
China, which had an annual mean of 13,809 cases 
between 2004 and 2015 corresponding to an incidence 
of 0.98 cases per 100,000 population [9]. In Europe, 
two known hotspots of infection are Finland with an 
average of 1,500 cases annually and morbidity as high 
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as 30 per 100,000 population [10,11] and Russia with 
around 7,500 cases annually on average and morbid-
ity of around six per 100,000 population [10,12]. Since 
2001, when hantavirus disease became notifiable 
in Germany, up to 3,000 reported cases have been 
observed annually; making Germany an additional hot-
spot of hantavirus disease in Europe. Besides the dom-
inating Puumala virus (PUUV) associated with the bank 
vole (Myodes glareolus), the Dobrava-Belgrade (DOBV) 
virus (type Kurkino), associated with the striped field 
mouse (Apodemus agrarius), is the second human 
pathogenic hantavirus endemic to Germany with a dif-
ferent geographical distribution and fewer cases per 
year [13].
The aim of this study was to describe the epidemiol-
ogy, space-time variation and clinical features of PUUV 
and DOBV infections in Germany using data from 17 
years of molecular and epidemiological hantavirus 
surveillance.
Methods
Collection of data and materials
Surveillance data
Symptomatic hantavirus infections with laboratory 
confirmation have been notifiable in Germany since 
2001. Serological evidence or detection of viral RNA by 
reverse transcription-PCR (RT-PCR) is reported to the 
local public health department by the identifying labo-
ratory. The health department completes and verifies 
case information according to the national surveillance 
case definition (box). Based on available information, 
cases are assigned the likely virus species that caused 
the infection (e.g. PUUV, DOBV or unknown if a differ-
entiation is not possible based on serological results). 
Information about date of onset, clinical symptoms, 
hospitalisation, outcome and probable place of infec-
tion is requested from the patient or treating physician. 
Case data are anonymised and electronically transmit-
ted to the state health department and from there to 
the Robert Koch Institute, the national public health 
institute in Germany.
Molecular data
Serum samples of patients diagnosed with hantavi-
rus infections were referred to the national consulta-
tion laboratory for hantaviruses (Institute of Virology, 
Charité Berlin, Germany) by hospitals and physicians 
through a nationwide alert network. For this report, 
a total of 214 hantavirus nucleotide (nt) sequences 
(202 PUUV and 12 DOBV) obtained from samples 
received between 2001–17 were used for molecu-
lar analysis. All sequences have been deposited to 




This report describes laboratory-confirmed hantavirus 
infections with clinical symptoms reported 2001–17 as 
at 1 June 2018. For the data analysis, we applied the 
national surveillance case definition (box).
Data analysis was conducted using STATA 15 
(StataCorp, College Station, Texas, United States) and 
Microsoft Excel 2010. Statistical tests (chi-squared test 
or Fisher’s exact test) were used as appropriate. Maps 
were created using RegioGraph Analyse 16.0 (GfK SE, 
Nürnberg, Germany).
Molecular data
Samples were tested using a molecular screening 
assay based on the large (L) segment of the hantavi-
rus genome [14] and subsequently Sanger sequenced. 
PUUV RNA positive samples were further analysed 
using an assay based on the small (S) segment [15]. 
Novel sequences were processed in the software pack-
age Geneious v10.2 (Biomatters Ltd, Auckland, New 
Zealand) and compared with those from previous 
Box 
Robert Koch Institute reference case definition for 
hantavirus infections, Germany, 2001–2017 [47]
Clinical picture of acute hantavirus disease, defined as 
presence of at least one of the following symptoms:
• Fever (>= 38.5 °C)
• Haemorrhagic course of disease
• Renal impairment





- Heart or circulatory failure
- Lung infiltrates
- Muscle-, limb- or backache
- Myopia, acute onset
- Nausea
- Vomiting
AND laboratory confirmation, defined as a positive 
outcome of at least one of the following:
• Presence of hantavirus specific IgM or IgA confirmed 
by IgG
• Significant rise in hantavirus specific IgG in two 
consecutive samples
• Detection of hantavirus RNA using NAT

























































































































































































































































































































































































































































































































































studies [15-17]. Alignments were created by MUSCLE 
and improved using the gblocks algorithm as imple-
mented in SeaView v4 [18,19]. Maximum likelihood 
(ML) phylogenetic trees were inferred using the PhyML-
SMS server [20] based on alignments of 506 nt and 347 
nt for PUUV S and DOBV L segments, respectively. The 
best-fitting model of nt substitution was identified as 
HKY85 + G + I for the PUUV S based tree and the TN93 + I 
model for the DOBV L based tree. Trees were visualised 
using Fig Tree v1.4 (University of Edinburgh, Edinburgh, 
United Kingdom). Patristic distances (PD) were calcu-
lated using the package ape v4.1 for R [21]. Maps were 
created using RegioGraph Analyse 16.0 (GfK SE). A phy-
logenetic cluster is defined as four or more sequences 
with a maximum patristic distance (PD, evolutionary 
distances between sequences in a given tree) of 0.21 
nt substitutions per site (nss).
Results
In total, 12,148 cases of hantavirus disease were 
reported between 2001 and 2017, corresponding to 
a mean annual incidence of 0.87 cases per 100,000 
population (range: 0.09–3.51). Of 12,148 cases, 9,972 
(82.09%) had information on the likely virus species 
causing the infection; 9,714 (97.41%) were notified as 
PUUV infections, while 223 (2.24%) were notified as 
DOBV infection (Table 1).
Other reported virus species included one case with 
a travel history to Indonesia with a Seoul virus infec-
tion confirmed by PCR and sequencing [22] and three 
Hantaan virus infections after returning from coun-
tries in south-east Asia. The additional 31 cases noti-
fied as Sin Nombre and Hantaan infections without a 
corresponding travel history are regarded as erroneous 
data entries and likely represent additional PUUV or 
DOBV infections. A total of 2,176 cases were notified 
not specifying the virus species; the distribution of 
these cases by time, place and person does not differ 
from those notified as PUUV or DOBV.
Between 2001 and 2017, there was geographical and 
temporal variation in incidence. The years with only few 
cases alternated with outbreak years showing a steep 
increase in weekly cases in spring/early summer and a 
high total case load. With a mean annual incidence of 
2.53 per 100,000 population, the four largest outbreak 
years 2007, 2010, 2012 and 2017, respectively, contrib-
uted 8,259/12,148 (68.0%) of the total cases reported 
between 2001 and 2017. In the remaining 13 years, the 
mean annual incidence was lower at 0.36 per 100,000 
population. Between 2001 and 2017, most cases were 
notified in the southern part of Germany with fewer 
cases in the west and only sporadic cases in the east 
(Figure 1). In total, 8,005/11,555 (69.28%) cases were 
hospitalised. The annual proportion of hospitalised 
cases (also an indicator of the overall sensitivity of the 
surveillance system) showed no clear long-term trend 
(Table 1).
Of 11,261 cases with information on the likely place 
of infection, 10,974 (97.45%) had likely acquired the 
infection in Germany while 228 (2.02%) and 59 (0.52%) 
infections were likely acquired in other European and 
non-European countries, respectively. Within Germany, 
hantavirus infections predominantly occurred in well-
known PUUV endemic areas e.g. the Swabian Jura in 
the state of Baden-Württemberg, the Bavarian Forest 
Figure 1
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Inlay shows the location of the regions within an outline of Germany.
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Figure 2


















PUUV: Puumala virus; DOBV: Dobrava-Belgrade virus.
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in the state of Bavaria or the Münster/Osnabrück 
region at the border of North-Rhine-Westphalia and 
Lower Saxony. DOBV infections were notified pre-
dominantly from counties in the north and the east of 
Germany.  Figure 2  maps the mean annual incidence 
over 17 years. During outbreak years, however, several 
counties in PUUV endemic areas reached annual 
incidences between 50 and 90 per 100,000 population.
Cases of PUUV infections (by month of disease onset) 
typically started to increase in late winter/early spring, 
peaked in May/June before decreasing through late 
summer and autumn (Figure 3A). Rising case num-
bers in autumn and winter months were typically fol-
lowed by large PUUV outbreak years. In contrast, DOBV 
infections occurred mostly during autumn and winter 
(158/215; 73.49%) with a peak in November (Figure 3B).
Age-specific incidence was highest in persons aged 
20–60 years old, peaking in the age group 40–49 
(mean annual incidence 1.54/100,000 population). In 
all age groups, incidence among men was higher com-
pared with women, 2.51-fold over all age groups (Figure 
4).
Fever, renal impairment, headache and muscle-, limb- 
or backaches were the most often reported symptoms 
among notified cases (all present in > 50% of cases). 
Renal impairment was more frequently reported among 
male compared with female patients, while headache, 
nausea, vomiting and acute onset of myopia was more 
frequent among female patients (all p < 0.01, respec-
tively Table 2).
In six cases, an acute hantavirus infection may have 
contributed to the death of the patient. These included 
two haemorrhagic courses of PUUV infection in 
patients aged 65 years and older and three non-haem-
orrhagic courses of PUUV infection in patients with co-
morbidities. An additional death occurred in a young 
man with DOBV (genotype Sochi) infection (confirmed 
by sequencing) after travel to the Caucasus region.
Phylogenetic and phylogeographic analyses
Viral nt sequences were obtained from samples 
referred to the national consultation laboratory for 
hantaviruses between 2004 and 2017. Sequences from 
202 patients were used for molecular analysis of PUUV, 
59 of these from the 2017 epidemic. Of these, 189/202 
(93.6%) fall into well-supported phylogenetic clusters 
(Munsterland, Teutoburg Forest, North-east Hesse, 
Spessart Forest, Bavarian Forest, Thuringia, Swabian 
Jura; Figure 5). The average PD within one cluster in the 
present dataset is 0.05 nss. Sequences within one of 
these geographical clusters show a pairwise identity 
of > 90%, whereas sequences from different clusters 
range from 81% (between Munsterland and Spessart 
Forest) and 87.9% (between Munsterland and Bavarian 
Forest).
Figure 6  shows the place of residence of all patients 
with PUUV infections between 2004 and 2017 where 
information was available. PUUV cases are indicated 
as squares coloured according to phylogenetic clusters 
in Figure 5. Of 189 cases, the sequence in 180 (95.24%) 
cases belonged to a cluster of sequences from patients 
of the same area of residence. These include three 
cases where the sequence clustered with sequences 
from an area the patient had travelled to before symp-
tom onset. For one sample (12/H463), no information 
on residency was available. In nine cases geographi-
cal and phylogenetic clusters were discrepant, but the 
Figure 3
Notified cases of hantavirus disease by notified virus 
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B. Dobrava-Belgrade virus (n=215)
Figure 4
Mean annual incidence of notified cases of hantavirus 


























































putative place of infection was mostly within short geo-
graphic distance.
Since 2008, DOBV sequences could be amplified from 
12 human samples referred to the national consulta-
tion laboratory (Figure 7). One sequence was obtained 
from a patient hospitalised in Istanbul, Turkey and was 
identified as DOBV genotype Dobrava [23]. Another 
sequence was amplified from a Russian patient hospi-
talised in Heidelberg and was clearly distinct from all 
other European DOBVs, belonging to the DOBV geno-
type Sochi [24]. The remaining 10 sequences were iden-
tified as DOBV genotype Kurkino. All patients carrying 
the Kurkino genotype were living in the north-eastern 
part of Germany.
Discussion
We analysed data from 17 years of epidemiological 
and molecular hantavirus surveillance in Germany. We 
found pronounced space-time variability in disease 
incidence, clear but divergent seasonality of sympto-
matic PUUV and DOBV infections, distinct geographi-
cal clusters of PUUV strains and differences in disease 
presentation between women and men.
The complexity of hantavirus epidemiology is high-
lighted by the spatio-temporal variation of disease in 
the population. It is driven by interactions between 
the virus, reservoir animals, humans as a dead-end 
host and factors such as weather and climate influenc-
ing environmental conditions and human and animal 
behaviour [25,26]. In Germany, the principal geographi-
cal distribution of PUUV- and DOBV endemic areas, as 
indicated by both serology-based surveillance data 
and our phylogeographic analysis of hantavirus nt 
sequences, can be explained by the distribution of the 
respective reservoir animals (the western evolutionary 
lineage of the bank vole and the striped field mouse, 
respectively) [27]. While no statistically significant dif-
ferences were observed in terms of the age- and sex 
distribution of the affected population and the course 
of disease, hantavirus epidemiology in PUUV and DOBV 
endemic areas differ fundamentally in other aspects: 
The typical ‘outbreak years’ and vastly fluctuating 
annual case numbers are only apparent in the regions 
where PUUV infections occur. In contrast, the number 
of annually reported cases due to DOBV infection is 
comparably stable (12–31 cases annually between 2013 
and 2017). The climatic and ecological factors leading 
to marked oscillations in the population density of M. 
glareolus seem to be much less important for members 
of the Apodemus genus, the DOBV reservoir. Moreover, 
the main seasonal periods for virus transmission to 
humans (disease incidence peaks in May/June and 
October–December for PUUV and DOBV infections, 
respectively) differ. This suggests that the period of 
Table 2
Absolute and relative frequency of symptoms by 





n % n %
Fever (>= 38.5 °C) 7,423 86.6 3,064 86.2 NS
Renal impairment 5,827 68.0 2,295 64.6 < 0.01
Muscle-, limb- or 
backache 5,583 65.1 2,329 65.5 NS
Headache 4,536 52.9 2,069 58.2 < 0.01
Nausea 2,036 23.7 1,120 31.5 < 0.01
Vomiting 1,553 18.1 846 23.8 < 0.01
Diarrhoea 1,159 13.5 467 13.1 NS
Cough 934 10.9 411 11. 6 NS
Dyspnoea 437 5.1 217 6.1 NS
Myopia, acute onset 415 4.8 221 6.2 < 0.01
Heart or circulatory 
failure 150 1.8 70 2.0 NS
Lung infiltrates 66 0.8 37 1.0 NS
Haemorrhagic course 
of disease 17 0.2 11 0.3 NS
Total 8,576 100 3,555 100 NA
NA: not applicable; NS: not statistically significant.
a Fisher’s exact p value.
Figure 5
Phylogenetic analysis of Puumala virus sequences in 
samples referred to the German consultation laboratory, 
Germany, 2004–2017
a
a Marks a sequence obtained from a patient with a travel history to 
Finland (07/H317).
Colour indicates putative geographic clusters as defined in the 
text; grey branches refer to sequences not yet assigned to any 
clear-defined phylogeographic cluster (i.e. < four sequences per 
region).
Maximum likelihood (ML) tree based on a 506 nt alignment of 
partial S segments of Puumala virus. ML tree was calculated 
using the HKY85 + G + I model of nt substitution; scale bar 
indicates nt substitutions per site. Bootstrap values are given 
for relevant clades, if above 750 (75%).
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Figure 6
Place of residence of cases of hantavirus disease with available hantavirus nt sequences, Germany, 2004–2017 (n = 210)
N
200 km
Cases caused by Puumala virus are depicted by squares coloured according to phylogenetic clusters (Figure 5). Grey squares refer to 
sequences not yet assigned to any clear-defined phylogeographic cluster (i.e. < 4 sequences per region). Dobrava-Belgrade virus–infected 
cases are depicted as black triangles.
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highest population density and infection prevalence 
in the respective reservoir animal and/or the contact 
pattern with humans is different for PUUV and DOBV 
infections. Risk-factors and prevention measures 
established for PUUV infections [28,29] might, there-
fore, not be targeting DOBV infections.
The epidemiology of PUUV in endemic areas and 
underlying factors have been studied extensively and 
much of the variation in disease incidence in central 
and western Europe may be explained by population 
increases of the bank vole following masting events of 
the common beech (Fagus sylvaticus) and other seed-
producing trees/plants [30]. Some authors have pro-
posed statistical models to predict outbreak years in 
PUUV endemic areas. Most of these models take into 
account the regional intensity of beech mast [31,32], 
which is a major factor driving overwintering efficiency 
and population density of the bank vole. Others con-
sider measurements of rodent density of or even virus 
prevalence in the reservoir, which requires labour-
intensive field- and laboratory work [33] but allows 
assessment of more direct influences of the probability 
of virus transmission to humans. More recently, mod-
els relying on climate/weather and habitat (e.g. density 
of deciduous forests) data alone, have been proposed 
for outbreak prediction [34]. These predictions can 
be helpful in raising awareness and preparedness for 
the disease and a coming increased risk of infection. 
However, as our data show, predicting whether the fol-
lowing year will be an outbreak year seems also pos-
sible by merely observing an increase in weekly case 
numbers through autumn and winter.
The distribution of our cases by age and sex show a 
higher incidence among males compared with females 
and a peak incidence among those aged 30–59 years, 
confirming prior findings from Germany and other 
European countries [35,36]. Apart from sex-specific 
differences in the exposure to pathogens, women and 
men also differ in their physiological responses to 
infections [37]. This is in line with our finding of statisti-
cally significant differences in the frequency of clinical 
symptoms in females and males, e.g. renal impairment 
(more frequent among male cases), headache, nausea, 
vomiting and acute onset of myopia (more frequent 
among female cases). In a study overseeing 108 well-
characterised patients from Germany, Krautkrämer 
and colleagues [38] did not observe major differences 
in disease severity between males and females, while 
studies from Sweden observed a higher case fatality 
rate among women [39].
While changing climate conditions might have increased 
the frequency of strong masting events leading to large 
outbreaks as observed during the past years [40], PUUV 
endemic areas in Germany seem stable. Comparison 
of all available human PUUV sequences from German 
patients between 2004 and 2017 shows that the 
vast majority falls into distinct clusters that can be 
assigned to specific geographical areas and that those 
clusters and areas remained stable during the past 13 
years. The existence and stability of these geographic 
clusters (including clusters of neighbouring areas) indi-
cate long-term separate evolution of strains in the ani-
mal reservoir and argue against a rapid expansion of 
areas where the virus is present in the environment. 
This is in line with our previous investigation of an out-
break of PUUV in the state of western Thuringia where 
the phylogenetic analysis suggested the steep rise in 
human cases was most likely caused by a proliferation 
of the population of infected voles rather than a recent 
spread of the virus from other areas [41].
Given the strong geographic association within > 90% 
of our hantavirus sequences and the close phyloge-
netic relationship between human and rodent derived 
sequences from the same area [15-17,42], there are 
strong indications that human infections commonly 
occur close to the cases homes. The few discrepan-
cies observed between phylogenetic cluster and the 
respective geographic location can be explained by 
the daily commute or travel history as reported by the 
case or are compatible with short (day) leisure trips. 
Using phylogenetic inference on our dataset, we were 
also able to identify sequences that do not originate 
in Germany, as shown for sample 07/H317. The patient 
had been exposed to rodents in Finland before fall-
ing ill, which is consistent with sequence data of the 
virus that was clearly distinct from German sequences 
[43]. Nine sequences that do not belong to any of the 
well-defined geographic clusters segregate into four 
distinct and well supported phylogenetic clades (> 98% 
bootstrap support). These might be affirmed as new 
geographic clusters once additional sequences from 
the corresponding regions become available. For those 
strains, rodent sequences from the same area would be 
desirable for confirmation. In order to investigate the 
possibility of reassortment events, which are known 
to occur in the rodent reservoirs [44], full-genome 
Figure 7
Phylogenetic analysis of Dobrava-Belgrade virus sequences 
in samples referred to the German consultation laboratory, 
Germany, 2004–2017
Maxiumum-likelihood (ML) tree based on a 347 nt aligment of 
partial L sequences of Dobrava-Belgrade virus. Scale bar gives nt 
substitutions per site; bootstrap values above 750 (75%) are given 
above branches. ML tree was calculated using the TN93 + I model.
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sequences of patients infected with PUUV should be 
obtained. However, this is challenging due to the typi-
cally very low viral RNA concentrations in the patient’s 
blood and short viraemia.
In this study, we used serological as well as sequenc-
ing-based data. Due to the large serological cross-reac-
tivity between virus species, typing based on serology 
alone can be misleading in an individual patient [45]. 
The overall concordance of PUUV and DOBV endemic 
areas determined through routine surveillance and 
sequencing data, however, was high and suggests 
that serology-based typing can be useful for surveil-
lance purposes. Still, continuous sequencing and phy-
logenetic analysis of circulating strains is necessary 
to detect the emergence of new strains (or the lack 
thereof) and is recommended to be done in at least a 
subsample of patients.
Conclusions
The presented data from 17 years of hantavirus surveil-
lance and research provides important insights into the 
epidemiology of both hantavirus species endemic in 
Germany. While in the past 10 years several exception-
ally large PUUV outbreaks have occurred in Germany, 
and the overall frequency of these outbreak years 
occurring might have increased due to climate factors, 
our data argues against an expansion of areas where 
the virus is present in the environment. Transmission 
routes and risk factors for human PUUV infections have 
been thoroughly investigated in several countries and 
studies but such studies are urgently needed for DOBV 
genotype Kurkino infections in order to develop DOBV-
specific recommendations for prevention. In con-
trast to infections with the DOBV-Dobrava genotype 
in south-east Europe, which are well studied, these 
infections are relatively rare and it may be worthwhile 
to pool data of several European countries, including 
Russia where this virus has been found in rodents and 
humans [46]. Regarding the clinical picture of hanta-
virus infections, we recommend medical practitioners 
to take into account that infections in men and women 
might present differently. Our data suggests that han-
tavirus infections are often acquired close to the home 
of the patient. In order to identify locally increased 
risks of infection and to better target public health rec-
ommendations, it would be helpful to collect and ana-
lyse case data of higher geographical resolution than 
just on a county level.
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